Flowflex™ rapid antigen test is the market-leading rapid antigen lateral flow, using nasal and nasopharyngeal swab samples. It is intended for use by trained clinical laboratory personnel and individuals trained in point of care settings.
|Authorized by Health Canada (IO # 327573)
|Approved for POC and Lab use REF# L031-11815
|25 Extraction tubes pre-filled with buffer solutions
|Nasal and nasopharyngeal swab samples
|Fast Results in 15 minutes
|Can also test specimens from asymptomatic individuals
|2 Years Shelf Life
|The most accurate test for the Omicron variant (independent validation study)
|25 Test Cassettes
|25 Sterile Nasal/Nasopharyngeal Swabs
|1 Positive Control Swab
|1 Negative Control Swab
25 Pre-filled Extraction Tubes
|1 Instruction for Use
Test Procedure and Interpretation
Results are for the identification of SARS-CoV-2 nucleocapsid antigen. This antigen is generally detectable in upper respiratory samples during the acute phase of infection.
|530 x 445 x 410mm
|Carton Gross Weight
|Packs / Carton
|32 packs of 25 tests / 800 tests per carton
|16 Cartons = 12,800 tests
The Flowflex SARS-CoV-2 Antigen Rapid Test is a lateral flow chromatographic immunoassay for the qualitative detection of the nucleocapsid protein antigen from SARS-CoV-2 in nasal swab specimens directly from individuals who are suspected of COVID-19 by their healthcare provider within the first seven days of the onset of symptoms.
|Relative Sensitivity - Nasal:
|Relative Specificity- Nasal:
|Accuracy - Nasal:
|Relative Sensitivity- Nasopharyngeal:
|Relative Specificity- Nasopharyngeal:
The tests are authorized for the following applications & settings:
- Lab-based tests, conducted in a lab environment by a trained laboratory technician.
- Point-of-care testing when used by an approved operator (often a health care professional) in a near-patient environment, such as a medical office or at the bedside. The patient waits for the results.
|INSTRUCTION FOR USE MANUAL (EN)
ACON Laboratories, Inc. is one of the nation’s largest capacity manufacturers of cost-effective rapid point-of-care diagnostic solutions, Immunoassays, and Molecular Diagnostics. ACON Laboratories, Inc. is the only legal manufacturer of the FDA EUA Flowflex™ COVID-19 Antigen Rapid Point of Care Test.